Genome & Company (KOSDAQ:314130)
South Korea · Delayed Price · Currency is KRW 6,880.00
-120.00 (-1.71%)
At close: Dec 30, 2025
Genome & Company Market Cap
Genome & Company has a market cap or net worth of 220.91 billion as of December 30, 2025. Its market cap has increased by 147.99% in one year.
Market Cap
220.91B
Enterprise Value
210.04B
Revenue
25.95B
Ranking
n/a
PE Ratio
n/a
Stock Price
6,880.00
Market Cap Chart
Since December 26, 2018, Genome & Company's market cap has increased from 71.88B to 220.91B, an increase of 207.34%. That is a compound annual growth rate of 17.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 29, 2025 | 224.77B | 163.79% |
| Dec 30, 2024 | 85.21B | -51.64% |
| Dec 28, 2023 | 176.21B | -28.34% |
| Dec 29, 2022 | 245.90B | -47.55% |
| Dec 30, 2021 | 468.83B | -55.28% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 767.46T |
| SK hynix | 413.58T |
| LG Energy Solution | 89.74T |
| Samsung Biologics | 78.32T |
| Hyundai Motor Company | 62.13T |
| Doosan Enerbility | 47.14T |
| Kia Corporation | 45.91T |
| HD Hyundai Heavy Industries | 45.45T |